Arnaud Massenet, a director at Better Home & Finance (BETR), converted 11,327 Restricted Stock Units (RSUs) into an equal number of Class A common shares on June 9, 2026, at a price of $0.00 per share. This transaction increased his direct holdings to 39,170 Class A shares. The filing notes a 1-for-50 reverse stock split on August 16, 2024, and confirms the RSUs vested on June 9, 2026.
Michael J. Farello, a
Apogee Therapeutics, Inc. reported a grant of 7,657 stock options to director Tomas Kiselak, with an exercise price of $85.00 per share. This routine equity compensation vests on the one-year anniversary of the grant date, subject to Kiselak's continued service. Kiselak holds the option for investment vehicles managed by Fairmount Funds Management LLC and disclaims beneficial ownership, as does Fairmount, except to the extent of its pecuniary interest.
Apogee Therapeutics director Nimish P. Shah was granted 7,657 stock options with an exercise price of $85.00, expiring on June 9, 2036. These options vest on the one-year anniversary of the grant date and are held for the sole benefit of Venrock Management, LLC. Shah is considered an indirect beneficial owner only to the extent of his pecuniary interest.

Apogee Therapeutics director Mark C. McKenna was granted stock options for 7,657 shares at an exercise price of $85.00 per share. These options will vest on the one-year anniversary of the June 9, 2026 grant date, provided his continued service, and are set to expire on June 9, 2036. This transaction is categorized as a grant or award acquisition rather than an open-market purchase.
Belden has announced the pricing of a $1.85 billion senior secured Term Loan B facility. This brief announcement was made through Refinitiv and is less than a minute read. The news indicates a significant financial move by Belden.

IQVIA Holdings Inc. (IQV) has completed a €950 million senior notes offering due in 2033 with an interest rate of 4.625% per annum. The proceeds will be used to refinance existing debt and cover offering-related fees. This strategic financial move aims to optimize IQVIA's capital structure and enhance its financial flexibility.

The Rosen Law Firm has filed a class action lawsuit against ADMA Biologics, Inc. on behalf of investors who purchased their securities between August 9, 2024, and March 25, 2026. The lawsuit alleges that ADMA Biologics made false and misleading statements by engaging in an undisclosed related party transaction, using channel stuffing to inflate revenue appearances, and lacking adequate internal controls. Investors who wish to serve as lead plaintiff must do so by August 10, 2026.

This article identifies Pathward Financial, Inc. (NASDAQ:CASH) as one of the 10 most profitable small-cap stocks, highlighting its strong financial performance. The company declared a cash dividend, reported substantial total assets and shareholders' equity, and was included in Keefe, Bruyette & Woods' 2026 Bank Honor Roll for consistent earnings growth and high EPS compound annual growth. Pathward Financial operates as a financial holding firm offering savings and loan services across various segments.

Five Star Bancorp has promoted Cliff Cooper to Executive Vice President and Food, Agribusiness & Diversified Industries President. With over 35 years of banking experience in food and agribusiness, Cooper will continue to lead the strategic direction and expansion of the bank's agribusiness operations. This promotion follows the bank's strong Q1 2026 financial results, outperforming market expectations, and comes as FSBC shares trade near their 52-week high.
Copyright © 2026 NiDCC All Rights Reserved.
